These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3925489)

  • 1. Effects of tiapride in tardive dyskinesia.
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J
    Psychopharmacology (Berl); 1985; 85(2):236-9. PubMed ID: 3925489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiapride in the treatment of tardive dyskinesia.
    Buruma OJ; Roos RA; Bruyn GW; Kemp B; van der Velde EA
    Acta Neurol Scand; 1982 Jan; 65(1):38-44. PubMed ID: 6121443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
    Greil W; Auberger S; Haag H; Rüther E
    Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of permanent tardive dyskinesia with tiapride, a selective D2-receptor blocking agent.
    Leblhuber F
    Clin Neuropharmacol; 1987 Oct; 10(5):458-61. PubMed ID: 2902921
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
    Roos RA; Van der Velde EA; Buruma OJ; de Wolff FA
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1055-8. PubMed ID: 3760895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiapride in levodopa-induced involuntary movements.
    Mejer Nielsen B
    Acta Neurol Scand; 1983 Jun; 67(6):372-5. PubMed ID: 6351529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of tardive dyskinesia.
    Roos RA; Buruma OJ; de Wolff FA
    Clin Neuropharmacol; 1988 Aug; 11(4):386. PubMed ID: 3061638
    [No Abstract]   [Full Text] [Related]  

  • 9. Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.
    Andersson U; Häggström JE; Nilsson MI; Widerlöv E
    Psychopharmacology (Berl); 1988; 94(2):167-71. PubMed ID: 2895483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.
    Roos RA; de Haas EJ; Buruma OJ; de Wolff FA
    Eur J Clin Pharmacol; 1986; 31(2):191-4. PubMed ID: 2948825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tardive dyskinesia.
    Deleu D
    Am J Psychiatry; 1988 Sep; 145(9):1182-3. PubMed ID: 2901238
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
    Pi EH; Simpson GM
    Mod Probl Pharmacopsychiatry; 1983; 21():80-6. PubMed ID: 6140635
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tiapride in the treatment of irreversible tardive dyskinesia--initial experiences].
    Leblhuber F; Reisecker F; Bengesser G
    Z Gerontol; 1987; 20(1):49-51. PubMed ID: 2883781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride.
    Koch HJ; Szecsey A; Vogel M; Fischer-Barnicol D
    Int J Clin Pract; 2003 Mar; 57(2):147-9. PubMed ID: 12661802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic trial of tiapride in extrapyramidal syndromes caused by neuroleptics].
    Zarranz JJ; Caso C; Blanco J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):503-8. PubMed ID: 6110319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term evaluation of tiapride in patients with various forms of dyskinesia].
    Nakajima Y; Kondo T; Narabayashi H
    No To Shinkei; 1985 Oct; 37(10):1013-9. PubMed ID: 4074571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiapride in tardive dyskinesia.
    Murphy DJ; Hughes G; Shaw GK
    Psychopharmacol Bull; 1982 Oct; 18(4):13-6. PubMed ID: 7156275
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):264-7. PubMed ID: 7373324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.